A Phase 2 Trial Testing ZP1848 in Patients With SBS

Update Il y a 4 ans
Reference: NCT02690025

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

A proof-of-concept, dose finding, controlled, single-center, randomized, double-blind, fixed dose phase 2 trial with ZP1848 in patients with Short Bowel Syndrome.


Inclusion criteria

  • Short Bowel Syndrome

Links